Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.

Barlin JN, Zhou QC, Leitao MM, Bisogna M, Olvera N, Shih KK, Jacobsen A, Schultz N, Tap WD, Hensley ML, Schwartz GK, Boyd J, Qin LX, Levine DA.

Neoplasia. 2015 Feb;17(2):183-9. doi: 10.1016/j.neo.2014.12.007.

2.

Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group Study.

Hensley ML, Miller A, O'Malley DM, Mannel RS, Behbakht K, Bakkum-Gamez JN, Michael H.

J Clin Oncol. 2015 Apr 1;33(10):1180-5. doi: 10.1200/JCO.2014.58.3781. Epub 2015 Feb 23.

PMID:
25713428
3.

Gynecologic Cancer InterGroup (GCIG) consensus review: uterine and ovarian leiomyosarcomas.

Hensley ML, Barrette BA, Baumann K, Gaffney D, Hamilton AL, Kim JW, Maenpaa JU, Pautier P, Siddiqui NA, Westermann AM, Ray-Coquard I.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S61-6. doi: 10.1097/IGC.0000000000000261.

PMID:
25341583
4.

Management of advanced uterine leiomyosarcoma.

Hyman DM, Grisham RN, Hensley ML.

Curr Opin Oncol. 2014 Jul;26(4):422-7. doi: 10.1097/CCO.0000000000000094. Review.

PMID:
24840518
5.

A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.

Campos SM, Brady WE, Moxley KM, O'Cearbhaill RE, Lee PS, DiSilvestro PA, Rotmensch J, Rose PG, Thaker PH, O'Malley DM, Hanjani P, Zuna RE, Hensley ML.

Gynecol Oncol. 2014 Jun;133(3):537-41. doi: 10.1016/j.ygyno.2014.02.036. Epub 2014 Mar 1. Erratum in: Gynecol Oncol. 2014 Dec;135(3):624.

PMID:
24594074
6.

Nomogram to predict cycle-one serious drug-related toxicity in phase I oncology trials.

Hyman DM, Eaton AA, Gounder MM, Smith GL, Pamer EG, Hensley ML, Spriggs DR, Ivy P, Iasonos A.

J Clin Oncol. 2014 Feb 20;32(6):519-26. doi: 10.1200/JCO.2013.49.8808. Epub 2014 Jan 13.

7.

Treatment outcomes in completely resected stage I to stage IV uterine carcinosarcoma with rhabdomyosarcoma differentiation.

Makker V, Kravetz SJ, Gallagher J, Orodel OP, Zhou Q, Iasonos A, DeLair D, Aghajanian C, Hensley ML.

Int J Gynecol Cancer. 2013 Nov;23(9):1635-41. doi: 10.1097/IGC.0000000000000001.

PMID:
24172099
8.

Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.

Barlin JN, Soslow RA, Lutz M, Zhou QC, St Clair CM, Leitao MM Jr, Iasonos A, Hensley ML, Barakat RR, Matias-Guiu X, Abu-Rustum NR.

Int J Gynecol Cancer. 2013 Nov;23(9):1620-8. doi: 10.1097/IGC.0b013e3182a5055e.

9.

Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees.

Barlin JN, Zhou Q, St Clair CM, Iasonos A, Soslow RA, Alektiar KM, Hensley ML, Leitao MM Jr, Barakat RR, Abu-Rustum NR.

Gynecol Oncol. 2013 Sep;130(3):452-6. doi: 10.1016/j.ygyno.2013.06.009. Epub 2013 Jun 14.

10.

Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.

Kim CH, Soslow RA, Park KJ, Barber EL, Khoury-Collado F, Barlin JN, Sonoda Y, Hensley ML, Barakat RR, Abu-Rustum NR.

Int J Gynecol Cancer. 2013 Jun;23(5):964-70. doi: 10.1097/IGC.0b013e3182954da8.

11.
12.

External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.

Iasonos A, Keung EZ, Zivanovic O, Mancari R, Peiretti M, Nucci M, George S, Colombo N, Carinelli S, Hensley ML, Raut CP.

Cancer. 2013 May 15;119(10):1816-22. doi: 10.1002/cncr.27971. Epub 2013 Mar 1.

13.

Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005).

Hensley ML, Wathen JK, Maki RG, Araujo DM, Sutton G, Priebat DA, George S, Soslow RA, Baker LH.

Cancer. 2013 Apr 15;119(8):1555-61. doi: 10.1002/cncr.27942. Epub 2013 Jan 18.

14.

Impact of incorporating an algorithm that utilizes sentinel lymph node mapping during minimally invasive procedures on the detection of stage IIIC endometrial cancer.

Leitao MM Jr, Khoury-Collado F, Gardner G, Sonoda Y, Brown CL, Alektiar KM, Hensley ML, Soslow RA, Barakat RR, Abu-Rustum NR.

Gynecol Oncol. 2013 Apr;129(1):38-41. doi: 10.1016/j.ygyno.2013.01.002. Epub 2013 Jan 12.

PMID:
23321065
15.

Management of uterine adenosarcomas with and without sarcomatous overgrowth.

Tanner EJ, Toussaint T, Leitao MM Jr, Hensley ML, Soslow RA, Gardner GJ, Jewell EL.

Gynecol Oncol. 2013 Apr;129(1):140-4. doi: 10.1016/j.ygyno.2012.12.036. Epub 2012 Dec 30.

PMID:
23283300
16.

Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution.

Barlin JN, Wysham WZ, Ferda AM, Khoury-Collado F, Cassella DK, Alektiar KM, Hensley ML, Chi DS, Barakat RR, Abu-Rustum NR.

Int J Gynecol Cancer. 2012 Nov;22(9):1527-31. doi: 10.1097/IGC.0b013e31827057e8.

PMID:
23051960
17.

Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients.

Sabbatini P, Tsuji T, Ferran L, Ritter E, Sedrak C, Tuballes K, Jungbluth AA, Ritter G, Aghajanian C, Bell-McGuinn K, Hensley ML, Konner J, Tew W, Spriggs DR, Hoffman EW, Venhaus R, Pan L, Salazar AM, Diefenbach CM, Old LJ, Gnjatic S.

Clin Cancer Res. 2012 Dec 1;18(23):6497-508. doi: 10.1158/1078-0432.CCR-12-2189. Epub 2012 Oct 2.

18.

High grade undifferentiated uterine sarcoma: surgery, treatment, and survival outcomes.

Tanner EJ, Garg K, Leitao MM Jr, Soslow RA, Hensley ML.

Gynecol Oncol. 2012 Oct;127(1):27-31. doi: 10.1016/j.ygyno.2012.06.030. Epub 2012 Jun 26.

PMID:
22750260
19.

Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.

Barlin JN, Dao F, Bou Zgheib N, Ferguson SE, Sabbatini PJ, Hensley ML, Bell-McGuinn KM, Konner J, Tew WP, Aghajanian C, Chi DS.

Gynecol Oncol. 2012 Jun;125(3):621-4. doi: 10.1016/j.ygyno.2012.03.027. Epub 2012 Mar 21.

PMID:
22446622
20.

Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.

Leitao MM Jr, Zivanovic O, Chi DS, Hensley ML, O'Cearbhaill R, Soslow RA, Barakat RR.

Gynecol Oncol. 2012 May;125(2):409-13. doi: 10.1016/j.ygyno.2012.02.014. Epub 2012 Feb 21.

PMID:
22366592
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk